Abstract
Introduction

1
eIF3e is a core component of the eIF3 multi-subunit translation initiation complex, which binds 2 directly to both the 40S ribosomal subunit and the cap-binding complex to facilitate ribosome 3 recruitment to mRNA (1). Specifically, the eIF3e subunit binds to the initiation complex scaffold 4 protein eIF4G (2), thereby linking 40S subunit recruitment to the translation initiation complex 5 (known as eIF4F) that binds to mRNA via the 7-methylguanosine cap. A recent study found that 6 expression of a truncated eIF3e protein that lacks normal eIF3e activity (i.e. the ability to bind to 7 eIF4G) causes both a decrease in global, cap-dependent translation initiation and a concomitant 8 increase in an alternative initiation mechanism that relies on RNA structures called internal 9 ribosome entry sites (IRES) (3), suggesting that decreased eIF3e activity creates an environment 10 that is favorable for mRNAs that rely on cap-independent translation.
11
Some translation initiation factors have been shown to be involved in cancer development 12 and progression (4) , most notably the cap-binding protein eIF4E (5) whose overexpression has 13 been correlated with many types of cancer (6), including breast (7,8) and lung (9) cancers. eIF3e 14 is also involved in cancer development, as loss of heterozygosity for the human eIF3e gene 15 (INT6) is found in 21% to 28% of breast tumors and reduced eIF3e expression is found in 37% 16 of breast cancers (10,11). These observations led to the hypothesis that eIF3e may act as a breast 17 cancer tumor suppressor. Recently, we discovered that decreased eIF3e expression in breast eIF3e has been correlated with both overall survival and disease-free survival for lung cancer 1 patients (13). These observations suggest that a reduction in eIF3e expression may be an 2 important event in lung cancer and contribute to the development and progression of this disease. 3 EMT is an important event in embryonic development; the conversion of epithelial cells 4 to mesenchymal cells, as well as the reverse process (mesenchymal-to-epithelial transition, 5 MET), allows the formation of adult tissues and organs (14) . EMT also plays a role in cancer 6 metastasis (15) , as the changes induced by EMT allow cancer cells to adopt migratory and 7 invasive properties that lead to the dissemination of tumor cells throughout the body. EMT is 8 regulated by a group of transcription factors (e.g. Snail1, Slug, Twist, and Zeb1/2) that 9 simultaneously induce the expression of genes required for mesenchymal properties and repress 10 the expression of genes required for the epithelial phenotype (16). As one of the initial events 11 during cancer metastasis, EMT begins with the dissolution of epithelial cell-cell junctions and 12 the loss of apical-basal polarity (14) . In addition, cells undergoing EMT display increased 13 expression of mesenchymal adhesion and marker proteins (e.g. N-Cadherin, Vimentin) resulting 14 in cytoskeletal reorganization and the acquisition of motility and a front-rear polarity. Finally, 15 cells undergoing EMT gain invasive properties through the expression of metalloproteases (17). 16 Transforming growth factor beta (TGF-β), a cytokine secreted by virtually all cell types, 17 is known to be a potent inducer of EMT (18, 19) . TGF-β signaling is transduced by the Smad and Snail1 to the regulatory promoter sequence of the CDH1 gene (encoding E-Cadherin). TGF-1 β has been shown to induce EMT in a variety of cell lines, including human alveolar epithelial 2 A549 cells (20) . Additionally, the use of TGF-β neutralizing antibodies has been shown to block 3 lung cancer metastasis in mammary-tumor bearing mice subjected to chemotherapy or radiation 4 (21). 5 In this study, we investigated the effect of decreased eIF3e expression in the human 6 alveolar adenocarcinoma cell line A549. We present evidence that these cells undergo EMT and 7 gain invasive and migratory properties upon a reduction in eIF3e expression. We also addressed 8 the molecular mechanisms involved in eIF3e-regulated EMT and find that upon decreased eIF3e 9 expression the selective translation of a subset of mRNAs that encode important proteins for 10 EMT progression occurs. Interestingly, we also show that decreased eIF3e expression in both 11 lung and breast epithelial cells leads to the overproduction and secretion of TGF-β and the 12 activation of the Smad signaling pathway. Significantly, our data indicate that the induction of 13 TGF-β production and signaling is essential for eIF3e-regulated EMT in A549 lung cancer cells. sequence. Single-cell clones were selected and maintained in 1.5 µg/ml puromycin (MCF-10A) 11 or 1 µg/ml puromycin (A549). Cells were treated with 10 µM of TGF-β inhibitor A-83-01 or absorbance at 254 nm was monitored using an ultraviolet spectrometer. RNA was purified from 3 each fraction as previously described (12) and used as a template for qRT-PCR. EMT through decreased eIF3e expression may be a universal phenomenon. 
Decreased eIF3e expression favors cap-independent translation of Zeb2 and Vimentin
13
We next sought to gain a better understanding of the molecular mechanisms by which a decrease 14 in eIF3e expression leads to EMT. Given that eIF3e is an important factor for translation 15 initiation mediated by the cap-dependent mechanism (2) and that expression of a truncated 16 version of eIF3e has been shown to cause a shift from cap-dependent to cap-independent 17 translation (3), we hypothesized that a decrease in eIF3e expression may lead to a decrease in are thought to be translated by a cap-independent mechanism (i.e. Zeb2 and Vimentin) (32, 33) . 
in eIF3e levels leads to a decrease in eIF4E phosphorylation. We examined the phosphorylation 1 status of eIF4E and found that it is less phosphorylated in cells that have reduced eIF3e 2 expression ( Figure S2 ). These observations partially explain why we fail to see an increase in 3 Snail1 translation despite the possible presence of an IRES in the SNAI1 5′ UTR. 4 Taken together, our results indicate that while global translation is decreased in A549 5 cells that have decreased eIF3e expression, the translation of a subset of mRNAs that are 6 important for the progression of EMT is maintained. We believe that cap-independent translation 7 of these mRNAs, possibly due to the presence of an IRES within the 5′ UTRs of these mRNAs, Reduced eIF3e expression leads to activation of the TGF-β signaling pathway 15 We next decided to investigate whether any signaling pathways that mediate EMT are affected 16 by a reduction in eIF3e expression. The progression of EMT is predominantly regulated by a 17 group of transcription factors that repress the expression of proteins involved in the epithelial 18 phenotype and induce the expression of proteins involved in the mesenchymal phenotype (31).
19
As described above, we have found that the EMT-regulating transcription factors Snail1, Zeb2, 20 and Slug are overexpressed in lung epithelial cells that have reduced eIF3e expression (Figure 3 ).
21
The expression of SNAI1 is known to be regulated by the TGF-β/Smad signaling In addition, we examined the expression of the TGFBI (Transforming growth factor beta-8 induced) gene, which is known to be induced by TGF-β signaling, and found that TGFBI is also Figure 6A ). In addition, using an ELISA assay, we measured TGF-β levels in the 1 conditioned cell culture media from A549 and MCF-10A cells harboring the scr or 205 shRNAs. 2 As shown in Figure 6B , conditioned cell culture media from A549 and MCF-10A cells with 3 reduced eIF3e expression have increased levels of TGF-β, demonstrating that a reduction in 4 eIF3e expression causes a marked increase in TGF-β production and excretion. 5 Given that our data indicate that global translation is decreased in A549 cells that harbor 6 the eIF3e-targeting shRNA ( Figure 4A ) and that TGFB1 mRNA does not have IRES activity 7 ( Figure 4C ), we chose to examine the translation status of the TGFB1 mRNA using the polysome 8 profiling strategy. As shown in Figure S3 , the TGFB1 mRNA is still associated with heavy 9 polysome fractions even when eIF3e levels are decreased. It has been recently suggested that 10 some mRNAs may be translated by a cap-independent mechanism that does not involve an IRES cancer aggressiveness and eIF3e expression in tumor samples has never been performed; 19 however, we believe that decreased translation associated with reduced eIF3e expression may be 20 an important event during the initiation of cancer metastasis. 21 We further show for the first time that reduced eIF3e expression in both breast and lung 22 epithelial cells activates TGF-β production and signaling. TGF-β has been known for some time 
to be a potent EMT inducer (44) and is now established as one of the main cytokines involved in 1 EMT induction (47). Our discovery that reduced eIF3e expression stimulates TGF-β production 2 in both lung and breast epithelial cells raises the intriguing possibility that TGF-β-induced EMT 3 may be a general phenomenon when global cap-dependent translation is compromised. Our data 4 indicate that several genes known to be activated at the transcriptional level by TGF-β signaling 5 also harbor IRES within their 5′ UTRs, which may be important for their translation when cap-6 dependent translation is compromised. Thus, it appears that a combination of transcriptional and 
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